Drug Shortage Report for CONRAY 30
Report ID | 3597 |
Drug Identification Number | 00223107 |
Brand name | CONRAY 30 |
Common or Proper name | Iothalamate Meglumine Injection 30 % |
Company Name | LIEBEL-FLARSHEIM CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | IOTHALAMATE MEGLUMINE |
Strength(s) | 300MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVASCULAR |
Packaging size | 250 mL |
ATC code | V08AA |
ATC description | X-RAY CONTRAST MEDIA, IODINATED |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | 2017-05-01 |
Actual start date | 2017-07-21 |
Estimated end date | Unknown |
Actual end date | 2018-03-14 |
Shortage status | Resolved |
Updated date | 2018-05-03 |
Company comments | Discontinued on March 14, 2018. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7500 TRANSCANADA HIGHWAY POINTE-CLAIRE, QUEBEC CANADA H9R 5H8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2018-05-03 | French | Compare |
v6 | 2018-05-03 | English | Compare |
v5 | 2018-01-23 | French | Compare |
v4 | 2018-01-23 | English | Compare |
v3 | 2017-05-02 | English | Compare |
v2 | 2017-03-20 | French | Compare |
v1 | 2017-03-20 | English | Compare |
Showing 1 to 7 of 7